AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 275: F535-F542, 1998;
0363-6127/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chansel, D.
Right arrow Articles by Ardaillou, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chansel, D.
Right arrow Articles by Ardaillou, R.
Vol. 275, Issue 4, F535-F542, October 1998

Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells

Dominique Chansel1, Stanislas Czekalski1, Sophie Vandermeersch1, Emmanuel Ruffet2, Marie-Claude Fournié-Zaluski2, and Raymond Ardaillou1

1 Institut National de la Santé et de la Recherche Médicale (INSERM) 64, Hôpital Tenon, 75020 Paris; and 2 INSERM 266-Centre National de la Recherche Scientifique Unité Associée 498, Université René Descartes, 75006 Paris, France

Because mesangial cells (MC) are a target and a degradation site for angiotensin II (ANG II), we characterized the degrading enzymes and receptors of ANG IV, a metabolite of ANG II, on these cells. ANG IV was metabolized into its NH2-terminal deleted peptides, ANG II-(4-8), ANG II-(5-8), and ANG II-(6-8) by rat MC. Total protection of ANG IV was obtained only when PC-18, a specific aminopeptidase N (APN) inhibitor, and JFH-27A, a mixed inhibitor of dipeptidylaminopeptidase (DAP) and neutral endopeptidase (NEP), were simultaneously added. In contrast, thiorphan, an NEP inhibitor, was inactive. These results demonstrate the exclusive role of APN and DAP in ANG IV degradation. 125I-labeled ANG IV binding was studied in the presence of PC-18 and JFH-27A to suppress ligand degradation. Under these conditions, ANG IV-specific receptors could be demonstrated with a KD of 1.8 nM and a density of 55 fmol/mg. In contrast with MC, no evidence for ANG IV receptors could be obtained in freshly isolated glomeruli. ANG IV stimulated cytosolic calcium concentration in MC, whereas its NH2-terminal deleted metabolites were inactive. Therefore, ANG IV must be protected from degradation by APN and DAP in studies on the nonimmediate biological effects of this peptide.

aminopeptidase N; cytosolic calcium; aminopeptidase inhibitor; angiotensin metabolites; dipeptidylaminopeptidase


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Wallis, M. F. Lankford, and S. R. Keller
Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1092 - E1102.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. C. Li, D. J. Campbell, M. Ohishi, S. Yuan, and J. L. Zhuo
AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1024 - F1033.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. K. Handa, S. E. Handa, and M. K. S. Elgemark
Autoradiographic analysis and regulation of angiotensin receptor subtypes AT4, AT1, and AT(1---7) in the kidney
Am J Physiol Renal Physiol, November 1, 2001; 281(5): F936 - F947.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns
Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. K. HANDA
Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
G. Wolf, U. Wenzel, K. J. M. Assmann, and R. A. K. Stahl
Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension
Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1935 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. K. HANDA
Metabolism Alters the Selectivity of Angiotensin-(1-7) Receptor Ligands for Angiotensin Receptors
J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1377 - 1386.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. K. Handa, J. W. Harding, and S. M. Simasko
Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Reaux, M. C. Fournie-Zaluski, C. David, S. Zini, B. P. Roques, P. Corvol, and C. Llorens-Cortes
Aminopeptidase A inhibitors as potential central antihypertensive agents
PNAS, November 9, 1999; 96(23): 13415 - 13420.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Loufrani, D. Henrion, D. Chansel, R. Ardaillou, and B. I. Levy
Functional Evidence for an Angiotensin IV Receptor in Rat Resistance Arteries
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 583 - 588.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online